Syphilis, toxoplasmosis, and cytomegalovirus represent disparate entities. The bacterial spirochaete Treponema pallidum ssp. pallidum causes syphilis, the 'The Great Imitator'; the organism's sole natural host is humans and it remains exquisitely sensitive to penicillin. By contrast, the zoonotic parasite Toxoplasma gondii causes toxoplasmosis. Infection is usually self-limited, although serious disease can occur in the immunocompromised. Meanwhile, the human cytomegalovirus (CMV; human herpesvirus 5) is a relatively prevalent enveloped DNA betaherpesvirus with infection specific to humans. Despite nomenclatural, ecological and therapeutic disparities, however, these agents exhibit several concordances, including various, and at times, cryptic syndromes in child and often mother; congenital infections with potentially devastating outcomes; diagnostic dilemmas. This article primarily discusses the latter of these issues in relationship to congenital syphilis and toxoplasmosis in the Australian context.
Syphilis
The number of cases of congenital syphilis has fallen in Australia over the past two decades (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) Additionally, the burden of disease in indigenous populations is well recognised, and it is possible that fly-in fly-out workers could transmit infections 3 . In the United States and United Kingdom re-emergence is also underway, and congenital infections have been linked particularly to primary and secondary syphilis in females [4] [5] [6] .
Given the potential for further spread in Australia, ongoing vigilance is required.
Vertical transmission is highest in primary and secondary syphilis, continuing throughout pregnancy while the severity of outcomes decreases 7 . Adverse outcomes can include stillbirth or miscarriage, perinatal death, prematurity, low birthweight, and a series of early congenital manifestations (e.g. snuffles, hepatosplenomegaly, generalised lymphadenopathy, bony lesions) and late congenital manifestations (typically due to chronic granulomatous inflammation) 4, 8, 9 .
In Australia, universal screening for syphilis is recommended in pregnancy, with a treponemal-specific serological assay performed at the first antenatal visit, and repeat screening in high-risk populations should be considered at 28 weeks 10, 11 . Modalities available for diagnosing congenital syphilis in Australia include both treponemalspecific and non-treponemal specific serology, nucleic acid detection, direct fluorescent antibody testing, and histochemical staining (e.g. Warthin-Starry silver stain) ( 
*
Awareness of the performance of non-treponemal serological tests (see Table 1 ), and reasons for misleading results ( Table 2) . 
Under the Microscope
For example, have false positives (e.g. biological) and false negatives (e.g. potentially methodological such as prozone 15 , or biological such as natural titre decline irrespective of therapy) been considered? Were separate serum specimens tested in parallel given inter-observer and inter-laboratory variation in endpoint determination 12 ?
* Awareness of potential weaknesses in treponemal-specific serological tests (see Table 1 ) and reasons for misleading results (Table 2 ). For example, has a false negative in a very recent exposure (i.e. before seroconversion) been considered? Such consideration is particularly warranted when history identifies possible exposure to syphilis (e.g. an infected partner), or examination reveals a chancre-like lesion.
* Awareness of sample selection. As an example, umbilical cord blood samples may be less preferable than infant serum given maternal blood contamination could incorrectly suggest congenital infection 16 .
* Awareness of sample management. As an example, recognition that seroreversion can occur with inappropriate storage conditions or freeze-thaw cycling (e.g. after repeated parallel testing) 17 .
*
Awareness of the utility of nucleic acid testing (NAT) testing. For example, confirmation of diagnosis may be achieved using paraffin-embedded tissue samples 12 .
* Adequate follow-up. For example, testing of an infant might be considered if maternal diagnosis of syphilis occurs within one year of delivery 18 .
Despite such considerations and well characterised testing pathways and definitions, and universally recommended testing, numerous factors could contribute to missed or incorrect diagnoses ( Disease occurs after maternal exposure to T. gondii via, for example, consumption of undercooked meat, or ingestion of oocyst contaminated soil and water 21, 22 . The frequency of vertical transmission after exposure increases as pregnancy proceeds, while disease severity typically declines 23 . Although most cases are subclinical, manifestations can be broad-ranging with sequelae unrecognised for decades 23 . Outcomes may include spontaneous abortion, still birth or prematurity, or manifestations such as The role of screening for toxoplasmosis has long been debated (e.g.
25
)
. The low incidence of toxoplasmosis in Australia translates to a low pre-test probability of infection. Combined with issues of 34 , and retesting the same specimen using a different IgM assay. Antenatal bloods may be retrospectively tested for IgM and IgG reactivity, and avidity. Confirmatory testing in low IgG avidity cases suggestive of recent infection may be via amniocentesis and NAT. Amniocentesis is not completely without risk 35 , and is not normally recommended in HIV positive patients 30 . However, it is associated with lower rates of pregnancy loss and has better diagnostic performance versus demonstration of fetal immunoglobulin by cordocentesis (e.g. 36 ). In high IgG avidity and/or IgM non-reactive cases suggestive of probable past infection, further investigation depends on gestation and exposure history.
When assessing for suspected congenital toxoplasmosis in a newborn, clinicians should perform a full clinical examination including ophthalmological assessment. Additional considerations include: * Placental histopathology (e.g. with Wright-Giemsa and immunoperoxidase stains) and NAT 29 . Historical methods include culture (e.g. cell line or mouse inoculation) 30 .
*
Serology of peripheral blood. Infant IgM and/or IgA reactivity likely suggests congenital infection, although exceptions exist (Table 3) . Other indicators include persistent IgG at 6 and 12 months 30, 37 . Single avidity scores from newborns may be difficult to interpret without further testing 38, 39 . Umbilical cord blood may be contaminated with maternal blood 30 .
Analysis of other sample types including cerebrospinal fluid and urine 37, 38 . Methods include NAT and serology (where appropriate). Diagnostic findings include IgM reactivity or target detection on NAT from cerebrospinal fluid 37 .
Imaging for hydrocephalus and calcifications 37 .
As for congenital syphilis, despite such considerations, diagnosis of congenital toxoplasmosis can still remain challenging and expert advice should be sought when considering testing, or interpreting test results. Ideally, investigation in women with substantially increased risk of infection should be considered before pregnancy 10 , and education regarding preventative measures provided.
